Captrust Financial Advisors Cv Sciences, Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	BUY	$0.37 - $1.18 $3,182 - $10,148	8,600 New	8,600 $5,000
Q4 2019 Feb 14, 2020	SELL	$0.86 - $2.58 $1,492 - $4,476	-1,735 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.72 - $4.24 $172 - $424	100 Added 6.12%	1,735 $3,000
Q2 2019 Aug 13, 2019	BUY	$3.93 - $6.08 $6,425 - $9,940	1,635 New	1,635 $7,000
Q3 2018 Nov 15, 2018	SELL	$1.6 - $7.13 $12,800 - $57,040	-8,000 Closed	0 $0

Q2 2018 Aug 13, 2018	BUY	$0.41 - $2.41 $3,280 - $19,280	8,000 New	8,000 $13,000

Ticker CVSI
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 147,794,000
Market Cap $7.39M
Description
CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense,...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.